There is a newer version
of
this Section
2017 Maryland Code
Health - General
Title 13 - Miscellaneous Health Care Programs
Subtitle 35 - Co-Prescribing of Opioid Overdose Reversal Drugs
§ 13-3501. Definitions.
Universal Citation: MD Health-Gen Code § 13-3501 (2017)
- (a) In general. -- In this subtitle the following words have the meanings indicated.
- (b) Co-prescribing. -- "Co-prescribing" means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose.
- (c) Opioid overdose reversal drug. -- "Opioid overdose reversal drug" means naloxone or a similarly acting and equally safe drug that is approved by the federal Food and Drug Administration for the treatment of a known or suspected opioid overdose.
Disclaimer: These codes may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
